Should we welcome such enhancements, whether with the technological assistance of “big pharma” or by the more artisanal means of “recreational” drugs? Or should we, in the name of emotional “authenticity”, insist that emotions are authentic only when their chemical infrastructure is entirely endogenic? The debate has barely begun (Kraemer 2011).